Keywords: spirig, gains, first, approval, s-optifen, based, egerkingen
Spirig Gains First Approval For S-Optifen
Article | 19 March 1997
Spirig, based in Egerkingen, Switzerland, has received its firstapproval from the Swiss regulatory authorities for S-Optifen (dexibuprofen), the active S(+) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
